Lexeo Therapeutics (LXEO) Q3 2024 Earnings

12AugConfirmed
Q4 2023
Q2 2024
Q3 2024
-0.86
-0.79
-0.71
-0.64

Details

Expected EPS
-0.691429
Actual EPS
-0.64
Surprise EPS
0.05
Surprise Percent
+7.44%

Description

Lexeo Therapeutics (LXEO) has reported earnings of -0.64 per share for Q3 2024.

0 Comments

Share your thoughts